| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |